On 3rd Sept. 2013, Fosun Pharma signed a strategic cooperative agreement with Guang Zhou Nan Yang Tumour Hospital Co., Ltd (hereinafter referred to as Guang Zhou Nan Yang Tumour Hospital). Fosun Pharama acquired 50% stake of Guang Zhou Nan Yang Tumour Hospital by acquiring ordinary shareholders’shares and capital expansion.

Guang Zhou Nan Yang Tumour Hospital is a tumour specialty hospital integrated with traditional Chinese as well as western medicine with the longest history in China. In 1978, China Cancer Research Foundation (CCRF) established Beijing Nan Yang Tumour Hospital under the supervision of the academician, Mr. Sun Yan, the founder of internal medical oncology. In 1993, Guang Zhou Nan Yang Tumour Hospital was established by introducing considerate foreign capital for the convenience of the patients from Southeast Asia. The hospital attracts leading domestic and foreign experts. With the leadship of Professor Luo Pengfei, the hospital set up Luo Pengfei micro-invasive therapeutic center, which makes the hospital a world-class micro invasive treatment provider and attracted numerous patients.

The hospital enjoys a high reputation in Mainland China, Hong Kong and Macau, and other Southeast Asian countries. It is the authorized medical institution with government health insurance of Guangdong Province. The hospital has a top-notch specialist team from both domestic and abroad, and holds the state-of–art technology and equipment. It is also an integration of Chinese and Western Medicine R&D and clinical base, which is good at tumor-treatment and is one of the famous micro invasive treatment bases in China. The hospital is popular in Indonesia, Malaysia, and is expanding the Vietnam market. Foreign patients take up 65 per cent of the overall business.

Fosun Pharma continuously develops its medical service business in recent years. The United Family Healthcare has been highly recognized as the premium brand for the high-end consumption crowd in China; Anhui Jimin Cancer Hospital is the first oncology specialty hospital in Anhui Province; Guangji Hospital of Yueyang and Suqian Zhongwu Hospital are both second-tier general hospitals and enjoy high reputation in their respective regions. Fosun Pharma takes Guang Zhou Nan Yang Tumour Hospital as an important platform in the high-end tumor specialty hospital sector along with the cooperation.

In the future, Fosun Pharma will continuously expand its medical service across the Pearl River delta regions and southern China, where it will kook for the M&A opportunities of the general hospitals and the specialty hospitals, and build a high standard hospital group cluster.